Riehen, Switzerland

Andrea Vaupel

USPTO Granted Patents = 31 

 

 

Average Co-Inventor Count = 5.8

ph-index = 9

Forward Citations = 245(Granted Patents)


Location History:

  • Wuppertal, DE (2002 - 2006)
  • CH 4125 Riehen, CH (2009)
  • Basel, CH (2011)
  • Riehen, CH (2003 - 2023)

Company Filing History:


Years Active: 2002-2025

where 'Filed Patents' based on already Granted Patents

31 patents (USPTO):

Title: Andrea Vaupel: Innovator in Pharmaceutical Research

Introduction

Andrea Vaupel is a notable inventor based in Riehen, Switzerland, recognized for his significant contributions to pharmaceutical research. With an impressive portfolio of 31 patents, Vaupel has made substantial advancements in the development of compounds that target critical biological pathways related to disease treatment.

Latest Patents

Among Vaupel's latest innovations are two significant patents. The first patent focuses on "Compounds and compositions for inhibiting the activity of HIF2-alpha and their methods of use." This invention describes specific compounds of formula (I) or their pharmaceutically acceptable salt forms, detailing their applicability in treating various diseases through pharmaceutical compositions.

The second patent, titled "Pyrazolyl derivatives useful as anti-cancer agents," presents compounds of formula (I) and their stereoisomers, including methods for their manufacture and therapeutic applications. This invention further explores combinations of pharmacologically active agents and related pharmaceutical compositions.

Career Highlights

Andrea Vaupel has had a distinguished career, contributing to top pharmaceutical companies, including Novartis AG and Bayer Aktiengesellschaft. His work in these esteemed organizations has enabled him to push the boundaries of innovation in drugs and treatment methodologies, focusing on therapies for complex diseases.

Collaborations

Vaupel has collaborated with several notable colleagues in his field, including Pascal Furet and Vito Guagnano. These collaborations enhance the innovative process, bringing together diverse expertise and perspectives to fuel advancements in medical science.

Conclusion

Andrea Vaupel’s dedication to innovation and excellence in pharmaceutical research is evident through his extensive patent portfolio and impactful career. His work continues to pave the way for new treatments, contributing meaningfully to the medical community and the lives of patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…